Loading BRVE…
SEC filing
BRVE · CIK 2131524
4 · Aug 10, 2026 · Jiangsu Hengrui Pharmaceuticals Co. converted 7.42M shares
Jiangsu Hengrui Pharmaceuticals Co. converted 7.42M shares
OWNERSHIP DOCUMENT
Graphics and non-inline formats (not embedded below).